Antimicrobial Stewardship of Oral Third-Generation Cephalosporins in Community Pharmacy: A Single-Center Quasi-Experimental Study

• Published in: Biological & pharmaceutical bulletin 2024/08/21, Vol.47(8), pp.1447-1451
• Main Authors: Nakamura, Koyo, Matsumoto, Kazuaki, Enoki, Yuki, Taguchi, Kazuaki, Yamashita, Shuji, Kai, Junko, Hayashi, Hideki
• Format: Article
• Language: English
• Subjects: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - therapeutic use; Antimicrobial agents; Antimicrobial resistance; antimicrobial stewardship; Antimicrobial Stewardship - methods; antimicrobial use density (AUD); Cephalosporins; Cephalosporins - therapeutic use; community pharmacy; Community Pharmacy Services; days of therapy (DOT); defined daily doses/prescription/month (DPM); Drug stores; Female; Humans; Infectious diseases; Male; Middle Aged; oral third-generation cephalosporin; Patients; Pharmacies; Pharmacy; Retrospective Studies; Young Adult
• ISSN: 0918-6158; 1347-5215; 1347-5215
• DOI: 10.1248/bpb.b24-00047

Proper use of antimicrobials in hospital and outpatient settings is critical for minimizing the occurrence of antimicrobial resistance. Some hospitals have intervened in the inappropriate use of third-generation oral cephalosporins. However, there have been no such studies in community pharmacy settings. This study aimed to investigate how the use of oral third-generation cephalosporins in community pharmacies affects the amount of antimicrobials used. Patients who visited Nakanomaru Pharmacy after being prescribed antimicrobials at target medical institutions between February 2021 and January 2023 were identified. The number of oral antimicrobials used, duration of use, number of prescriptions, patient age and sex, and infectious diseases in the target patients before and after the intervention for the proper use of oral third-generation cephalosporins were retrospectively investigated based on the patients’ medication history and prescription receipts. Through efforts to ensure the proper use of oral third-generation cephalosporins, the amount of oral third-generation cephalosporins used has decreased, and the use of penicillins and oral first-generation cephalosporins has increased. There was no increase in the antimicrobial change or relapse rates associated with treatment failure before and after the initiation of appropriate antimicrobial use. By working toward the proper use of oral third-generation cephalosporins in community pharmacies, we were able to reduce the doses of oral third-generation cephalosporins without compromising their therapeutic efficacy. We believe that recommending the selection of narrow-spectrum antimicrobials based on these guidelines will contribute to their proper use.